Zhejiang Starry Pharmaceutical Co.,Ltd. (SHA:603520)

China flag China · Delayed Price · Currency is CNY
9.99
+0.02 (0.20%)
May 27, 2025, 2:45 PM CST
-11.28%
Market Cap 4.37B
Revenue (ttm) 2.39B
Net Income (ttm) -47.04M
Shares Out 438.41M
EPS (ttm) -0.10
PE Ratio n/a
Forward PE 33.23
Dividend 0.20 (2.01%)
Ex-Dividend Date Sep 9, 2024
Volume 15,554,134
Average Volume 16,245,252
Open 10.00
Previous Close 9.97
Day's Range 9.77 - 10.07
52-Week Range 7.32 - 11.37
Beta 0.66
RSI 76.38
Earnings Date Apr 30, 2025

About SHA:603520

Zhejiang Starry Pharmaceutical Co.,Ltd. engages in the research and development, production, and sale of X-CT non-ionic contrast agents and fluoroquinolones drugs and intermediates in China and internationally. Its contrast agent products include iohexol, iohexol hydrolysate, iohexol iodide, ioversol, iopamidol, iomeprol, iopromide, cybeclamine, iodixanol, gadopentetic acid dimeglumine, and glutamate; and fluoroquinolones products, such as levofloxacin, levofloxacin hydrochloride, levoflurane, levofluorocarboxylic acid, pazufloxacin, and pazufl... [Read more]

Sector Healthcare
Founded 1997
Employees 1,754
Stock Exchange Shanghai Stock Exchange
Ticker Symbol 603520
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.